Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical translation of anti-inflammatory effects of Prevotella histicola in Th1, Th2, and Th17 inflammation
Andrea Itano, Douglas Maslin, Kritika Ramani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 13

Showing 13 citing articles:

Gut microbiota and their metabolites in the immune response of rheumatoid arthritis: Therapeutic potential and future directions
Xiaoyu Cai, Fujia Ren, Yao Yao
International Immunopharmacology (2025) Vol. 147, pp. 114034-114034
Closed Access | Times Cited: 2
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 111-111
Open Access | Times Cited: 11
The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies
Diana Sabina Radaschin, Alin Laurenţiu Tatu, Alina Viorica Iancu, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1619-1619
Open Access | Times Cited: 6
Weizmannia coagulans BC99 modulate gut microbiota after Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial
Ying Wu, Shirui Zhai, Caie Wang, et al.
Journal of Functional Foods (2025) Vol. 125, pp. 106681-106681
Closed Access
The Future of Microbiome Therapeutics
Milena Pitashny, Inbar Kesten, Dima Shlon, et al.
Drugs (2025)
Open Access
Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs
Li Tian Keane Teo, Nerissa Juantuah-Kusi, Gowtham Subramanian, et al.
Non-Coding RNA (2025) Vol. 11, Iss. 1, pp. 16-16
Open Access
New and emerging oral therapies for psoriasis
Orhan Yılmaz, João Pedro Pinto, Tiago Torres
Drugs in Context (2024) Vol. 13, pp. 1-24
Open Access | Times Cited: 3
Gut microbiota and transcriptome dynamics in every-other-day fasting are associated with neuroprotection in rats with spinal cord injury
Junyu Wang, Xiaohua Zhao, Ruihan Zhou, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Wen Fan, Na Lei, Yujie Zheng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses — a randomized, placebo-controlled clinical trial
Boukje C. Eveleens Maarse, Micha Nathaniel Ronner, Manon A. A. Jansen, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 776-787
Open Access
Zinc oxide nanoparticles improve lactation and metabolism in dairy goats by modulating the rumen microbiota
Shan Xie, Ying Zhang, Ziqing Xiu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Comparison of oral microbiome diversity between children and young adults in Korea
Jung Hwa Park, Si Yeong Kim, Jin Woo Chung, et al.
International Journal of Oral Biology (2024) Vol. 49, Iss. 4, pp. 100-109
Closed Access
Evaluation of single-strain Prevotella histicola on KLH-driven immune responses in healthy volunteers: A randomized controlled trial with EDP1815
Mahdi Saghari, Pim Gal, Hendrika W. Grievink, et al.
Medicine in Microecology (2023) Vol. 19, pp. 100088-100088
Open Access
Page 1

Scroll to top